Incyte
INCY
#1203
Rank
C$26.30 B
Marketcap
C$131.68
Share price
1.72%
Change (1 day)
52.35%
Change (1 year)

EPS for Incyte (INCY)

EPS in 2025 (TTM): C$9.13

According to Incyte's latest financial reports the company's current EPS (TTM) is C$8.97. In 2024 the company made an earnings per share (EPS) of C$0.42 a decrease over its 2023 EPS that were of C$3.63.

EPS history for Incyte from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)C$9.132066.66%
2024C$0.42-88.39%
2023C$3.6373.38%
2022C$2.09-64.1%
2021C$5.83-408.63%
2020C-$1.89-166.83%
2019C$2.83300%
2018C$0.71-133.33%
2017C-$2.12-378.57%
2016C$0.762700%
2015C$0.02718-106.67%
2014C-$0.41-44.44%
2013C-$0.7350%
2012C-$0.49

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Novartis
NVS
C$9.78 9.09%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
C$1.85-79.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$31.29 248.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
C$19.47 117.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
C$8.56-4.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Geron
GERN
C-$0.18-101.97%๐Ÿ‡บ๐Ÿ‡ธ USA
CTI BioPharma
CTIC
C-$0.79-108.79%๐Ÿ‡บ๐Ÿ‡ธ USA
AVEO Oncology
AVEO
C-$1.14-112.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
C-$0.34-103.79%๐Ÿ‡บ๐Ÿ‡ธ USA